Cargando…
Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma
Our pathological study of a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma suggested that immune checkpoint inhibitor may be an effective therapy. The histological type is an important factor in determining treatment choices.
Autores principales: | Omori, Ginji, Osuga, Takahiro, Miyanishi, Koji, Hamaguchi, Kota, Tanaka, Shingo, Ohnuma, Hiroyuki, Murase, Kazuyuki, Takada, Kohichi, Nagayama, Minoru, Kimura, Yasutoshi, Takemasa, Ichiro, Kikuchi, Yasuhiro, Torigoe, Toshihiko, Kato, Junji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428809/ https://www.ncbi.nlm.nih.gov/pubmed/34522383 http://dx.doi.org/10.1002/ccr3.4764 |
Ejemplares similares
-
A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib
por: Osuga, Takahiro, et al.
Publicado: (2022) -
Association between Hepatic Oxidative Stress Related Factors and Activation of Wnt/β-Catenin Signaling in NAFLD-Induced Hepatocellular Carcinoma
por: Hamaguchi, Kota, et al.
Publicado: (2022) -
A case of acute exacerbation of chronic hepatitis C during the course of adrenal Cushing's syndrome
por: Osuga, Takahiro, et al.
Publicado: (2022) -
A case of hypervascular tumors in the liver and pancreas: synchronous hepatocellular carcinoma and pancreatic metastasis from renal cell carcinoma 36 years after nephrectomy
por: Nakamura, Hajime, et al.
Publicado: (2020) -
Successful mycophenolate mofetil treatment of a patient with severe steroid‐refractory hepatitis evoked by nivolumab plus ipilimumab treatment for relapsed bladder cancer
por: Omori, Ginji, et al.
Publicado: (2020)